Kyverna Therapeutics Stock Forecast

Hold candidate since Jun 22, 2026

The Kyverna Therapeutics, Inc. stock price gained 2.85% on the last trading day (Monday, 22nd Jun 2026), rising from $8.07 to $8.30. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.97% from a day low at $8.15 to a day high of $8.56. The price has risen in 8 of the last 10 days and is up by 11.11% over the past 2 weeks. Volume fell on the last day by -543 thousand shares and in total, 909 thousand shares were bought and sold for approximately $7.54 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.88% during the next 3 months and, with a 90% probability hold a price between $6.84 and $9.97 at the end of this 3-month period.

KYTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 11.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kyverna Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $8.67. On a fall, the stock will find some support from the short-term average at $8.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Kyverna Therapeutics, Inc. stock

Kyverna Therapeutics, Inc. finds support from accumulated volume at $8.07 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.405 between high and low, or 4.97%. For the last week, the stock has had daily average volatility of 5.37%.

Our recommended stop-loss: $8.01 (-3.48%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (KYTX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Kyverna Therapeutics, Inc. to open at $8.34, and during the day (based on 14 day Average True Range), to move between $8.04 and $8.56, which gives a possible trading interval of +/-$0.513 (+/-6.38%) up or down from last closing price. If Kyverna Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.07 (2.77%) than the resistance at $8.70 (4.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kyverna Therapeutics, Inc. stock A Buy?

Kyverna Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.971 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $8.34 ( 0.422%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk